Page last updated: 2024-09-03

cimadronate and Invasiveness, Neoplasm

cimadronate has been researched along with Invasiveness, Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirano, K; Iguchi, K; Nakano, T; Usui, S1
Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S; Tanaka, K; Yasunaga, Y1

Other Studies

2 other study(ies) available for cimadronate and Invasiveness, Neoplasm

ArticleYear
Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
    Cancer letters, 2006, Jun-18, Volume: 237, Issue:2

    Topics: Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cytosol; Diphosphonates; Enzyme Inhibitors; Humans; Leucine; Male; Mevalonic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; rap1 GTP-Binding Proteins

2006
Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2006, Volume: 24, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Sarcoma; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2006